Preventing muscle atrophy

Dr. Stephen Burden and colleagues demonstrate that the DNA-binding protein, Runx1 (AML1), directs the expression of 29 genes involved in the prevention of skeletal muscle wasting. Using mice deficient in runx1 specifically in skeletal muscle cells, the researchers determined that Runx1 activation is necessary to sustain muscle by limiting the autophagy of denervated myofibers.

Dr. Burden believes that their findings “raise the intriguing possibility that congenital myopathies, which do not follow simple Mendelian inheritance or become evident only late in life, may require two initiating events: a decrease in muscle activity, due to trauma, aging, or immobilization, as well as a mutation in Runx1 or its target genes.”

Media Contact

Heather Cosel EurekAlert!

More Information:

http://www.cshl.edu

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Combining robotics and ChatGPT

TUM professor uses ChatGPT for choreographies with flying robots. Prof. Angela Schoellig has proved that large language models can be used safely in robotics. ChatGPT develops choreographies for up to…

How the Immune System Learns from Harmless Particles

Our lungs are bombarded by all manner of different particles every single day. Whilst some are perfectly safe for us, others—known as pathogens—have the potential to make us ill. The…

Biomarkers identified for successful treatment of bone marrow tumours

CAR T cell therapy has proven effective in treating various haematological cancers. However, not all patients respond equally well to treatment. In a recent clinical study, researchers from the University…

Partners & Sponsors